Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia

Overview of attention for article published in Frontiers in immunology, December 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 11,892 followers.

New article: Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia. https://t.co/0A9BGzwql0 #AML #leusm #hematology https://t.co/wjkF0nUuip

RT @CARTTherapy: Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell A…

RT @CARTTherapy: Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell A…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.